This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Roquette Freres. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Roselyne Bernard: Innovator in Biological Assays
Introduction
Roselyne Bernard is a prominent inventor based in Lestrem, France. She has made significant contributions to the field of biological assays, particularly in the dosage and assay of peptidoglycans. With a total of 2 patents, her work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Bernard's latest patents include innovative methods for the biological dosage and assay of peptidoglycans. The first patent, titled "Biological dosage of peptidoglycans," describes a biological method for determining the dosage of peptidoglycans in samples, especially those containing glucose polymers. The second patent, "Biological assay of peptidoglycans," outlines a comprehensive method for assaying peptidoglycans in samples. This method involves treating the glucose polymer sample through sonication, heating, and/or alkalizing, followed by interaction with a recombinant cell expressing an exogenous TLR2 and a reporter gene. The process culminates in measuring the reporter gene signal to determine the amount of PGN in the sample.
Career Highlights
Roselyne Bernard is currently employed at Roquette Frères, a company known for its expertise in plant-based ingredients and solutions. Her work at Roquette Frères has allowed her to focus on innovative research and development in the field of biological assays.
Collaborations
Throughout her career, Bernard has collaborated with notable colleagues, including Marc Biguet and Fabrice Allain. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Roselyne Bernard is a trailblazer in the field of biological assays, with her innovative patents paving the way for advancements in the understanding and application of peptidoglycans. Her contributions continue to impact the biotechnology sector positively.